Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what steps he is taking to ensure the same standard of care across the country for those diagnosed with prostate cancer.

To help reduce regional variations, the Care Quality Commission (CQC) is increasingly incorporating information from accreditation and peer review programmes into its assessments of National Health Service trusts' services, including the National Cancer Peer Review Programme. The CQC also intends to use data from the national clinical audit which is being developed for prostate cancer. In addition, national statistics on waiting times experienced by patients with suspected and diagnosed cancers continue to be collected, monitored and published in order to improve equity of access to cancer services and to contribute to an improvement in survival rates.

The results of the latest national Cancer Patient Experience Survey (CPES) from 2013 show that, whilst variations between trusts still exist, the overall range of variation for many indicators has narrowed. For example, in 2010 the proportion of patients saying that they had been given the name of a Clinical Nurse Specialist ranged from 92% in the highest performing trust to 59% in the poorest performing trust (33 points); by 2013 this had reduced to 97% to 76% (21 points).

NHS Improving Quality (NHS IQ) will be doing a suite of work across all surveys to understand what the barriers are to implementing change and to showcase best practice where real improvements can be demonstrated.

NHS England is working with NHS IQ to develop better ways of using the CPES data within the NHS in order to maximise the impact of the survey, to be able to work with successful and struggling organisations to spread best practice for example.